• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管护理中的器械监管与监测:挑战与机遇。

Device regulation and surveillance in vascular care: Challenges and opportunities.

机构信息

Division of Vascular Surgery and Endovascular Therapy, Keck Medical Center of University of Southern California, Los Angeles, California, USA.

Heart and Vascular Center, Dartmouth Health, Lebanon, New Hampshire, USA.

出版信息

Catheter Cardiovasc Interv. 2024 Jul;104(1):84-91. doi: 10.1002/ccd.31053. Epub 2024 Apr 19.

DOI:10.1002/ccd.31053
PMID:38639136
Abstract

Cardiovascular devices are essential for the treatment of cardiovascular diseases including cerebrovascular, coronary, valvular, congenital, peripheral vascular and arrhythmic diseases. The regulation and surveillance of vascular devices in real-world practice, however, presents challenges during each individual product's life cycle. Four examples illustrate recent challenges and questions regarding safety, appropriate use and efficacy arising from FDA approved devices used in real-world practice. We outline potential pathways wherein providers, regulators and payors could potentially provide high-quality cardiovascular care, identify safety signals, ensure equitable device access, and study potential issues with devices in real-world practice.

摘要

心血管设备对于治疗心血管疾病至关重要,包括脑血管、冠状动脉、瓣膜、先天性、周围血管和心律失常疾病。然而,在每个产品的生命周期中,实际应用中的血管设备的监管和监测都带来了挑战。四个例子说明了最近在实际应用中使用的经过 FDA 批准的设备在安全性、合理使用和疗效方面出现的安全、适当使用和疗效方面出现的挑战和问题。我们概述了提供者、监管者和支付者如何提供高质量的心血管护理、识别安全信号、确保设备公平获得以及研究实际应用中设备潜在问题的潜在途径。

相似文献

1
Device regulation and surveillance in vascular care: Challenges and opportunities.血管护理中的器械监管与监测:挑战与机遇。
Catheter Cardiovasc Interv. 2024 Jul;104(1):84-91. doi: 10.1002/ccd.31053. Epub 2024 Apr 19.
2
FDA perspectives on postmarket surveillance of peripheral and aortic vascular devices.美国食品药品监督管理局对外周血管和主动脉血管装置上市后监测的观点。
Catheter Cardiovasc Interv. 2024 Jul;104(1):170-171. doi: 10.1002/ccd.31087. Epub 2024 May 19.
3
How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?骨科器械在首次获得美国食品药品监督管理局(FDA)上市前批准后会发生怎样的变化?
Clin Orthop Relat Res. 2016 Apr;474(4):1053-68. doi: 10.1007/s11999-015-4634-x. Epub 2015 Nov 19.
4
Innovative postmarket device evaluation using a quality registry to monitor thoracic endovascular aortic repair in the treatment of aortic dissection.利用质量登记处对胸主动脉腔内修复术治疗主动脉夹层进行监测的创新性上市后器械评估。
J Vasc Surg. 2017 May;65(5):1280-1286. doi: 10.1016/j.jvs.2016.11.054. Epub 2017 Feb 16.
5
The Vascular Implant Surveillance and Interventional Outcomes (VISION) Coordinated Registry Network: An effort to advance evidence evaluation for vascular devices.血管植入物监测和介入治疗结局(VISION)协调注册网络:一项推进血管器械证据评估的努力。
J Vasc Surg. 2020 Dec;72(6):2153-2160. doi: 10.1016/j.jvs.2020.04.507. Epub 2020 May 20.
6
FDA regulation of cardiovascular devices and opportunities for improvement.美国食品药品监督管理局对心血管器械的监管及改进机遇。
J Interv Card Electrophysiol. 2013 Mar;36(2):99-105. doi: 10.1007/s10840-012-9767-1. Epub 2012 Dec 21.
7
Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.自动化监测以发现已批准心血管器械的术后安全性信号。
JAMA. 2010 Nov 10;304(18):2019-27. doi: 10.1001/jama.2010.1633.
8
Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.2010 年和 2011 年 FDA 上市前批准的高风险治疗性医疗器械全产品生命周期临床试验特点。
JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
9
Improving medical device regulation: the United States and Europe in perspective.改进医疗器械监管:美国和欧洲的视角。
Milbank Q. 2014 Mar;92(1):114-50. doi: 10.1111/1468-0009.12043.
10
Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements.外周介入器械注册评估(RAPID):外周介入器械注册评估核心数据元素。
J Vasc Surg. 2018 Feb;67(2):637-644.e30. doi: 10.1016/j.jvs.2017.07.141.